Why the study?
Variants in MYBPC1 have been implicated in developmental muscle diseases such as distal arthrogryposis, but how these variants cause disease is not well understood.
Does Mybpc1 knockout impair skeletal muscle development and growth in mouse models?
Does Mybpc1 knockout impair skeletal muscle development and growth in mouse models?
sMyBP-C plays an essential role in both prenatal embryonic musculoskeletal development and postnatal muscle growth and function.
Mouse models define sMyBP-C's role in muscle development; leaves open human relevance of MYBPC1 variants.
Skeletal muscle is the largest organ in the body, responsible for gross movement and metabolic regulation. Recently, variants in the MYBPC1 gene have been implicated in a variety of developmental muscle diseases, such as distal arthrogryposis. How MYBPC1 variants cause disease is not well understood. Here, through a collection of novel gene-edited mouse models, we define a critical role for slow myosin binding protein-C (sMyBP-C), encoded by MYBPC1 , across muscle development, growth, and maintenance during prenatal, perinatal, postnatal and adult stages. Specifically, Mybpc1 knockout mice exhibited early postnatal lethality and impaired skeletal muscle formation and structure, skeletal deformity, and respiratory failure. Moreover, a conditional knockout of Mybpc1 in perinatal, postnatal and adult stages demonstrates impaired postnatal muscle growth and function secondary to disrupted actomyosin interaction and sarcomere structural integrity. These findings confirm the essential role of sMyBP-C in skeletal muscle and reveal specific functions in both prenatal embryonic musculoskeletal development and postnatal muscle growth and function.
No takes yet. Share an insight, caveat, or question.
Song et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: